Erythropoietic Response to Anemia in Chronic Hepatitis C Patients Receiving Combination Pegylated Interferon/Ribavirin-Reference-Cited by-同舟云学术

Erythropoietic Response to Anemia in Chronic Hepatitis C Patients Receiving Combination Pegylated Interferon/Ribavirin

Published:2005-02 Issue:2 Volume:100 Page:299-307
ISSN:0002-9270
Container-title:The American Journal of Gastroenterology
language:en
Short-container-title:Am J Gastroenterology

Author:

Balan Vijayan,Schwartz David,Wu George Y.,Muir Andrew J.,Ghalib Reem,Jackson John,Keeffe Emmet B.,Rossaro Lorenzo,Burnett Alfreda,Goon Betty L.,Bowers Peter J.,Leitz Gerhard J.,

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference24 articles.

1. 1. PEG-Introntm (Peginterferon alfa-2b, recombinant) [package insert] . Kenilworth, NJ: Schering Corporation, 2002 .

2. 2. Copegustm (ribavirin, USP) [package insert] . Nutley, NJ: Hoffmann-LaRoche, Inc., 2002 .

3. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

4. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

5. Changes in haemoglobin during interferon alpha-2b plus ribavirin combination therapy for chronic hepatitis C virus infection

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence, risk factors and impact on virological response of anemia in chronic genotype 2 hepatitis C receiving sofosbuvir plus ribavirin;Journal of the Formosan Medical Association;2020-01

2. Does Epoetin Beta Still Have a Place in Peginterferon Alpha-2a Plus Ribavirin Treatment Strategies for Chronic Hepatitis C?;Journal of Interferon & Cytokine Research;2016-03

3. Ribavirin;Meyler's Side Effects of Drugs;2016

4. Reticulocyte production index as a predictor of clinically significant anemia in chronic hepatitis C patients receiving pegylated interferon combination therapy;Advances in Digestive Medicine;2015-04-22

5. Efficacy of pegylated interferon and ribavirin combination therapy for patients with hepatitis C virus infection after curative resection or ablation for hepatocellular carcinoma-A retrospective multicenter study;Journal of Medical Virology;2015-03-13